Drugs / RGB-10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02223416 | ? → Jan 2015 | — | Gedeon Richter Plc. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2019-09-20 | Mochida Pharmaceutical Company, Ltd. | Regulatory 骨粗鬆症治療剤「テリパラチドBS皮下注キット」の国内における製造販売承認取得のお知らせ mochida.co.jp ↗ |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2019-09-20 | Mochida Pharmaceutical Company, Ltd. | 骨粗鬆症治療剤「テリパラチドBS皮下注キット」の国内における製造販売承認取得のお知らせ mochida.co.jp ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RGB-10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02223416 ↗ |